Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer
International Journal of Urology, 03/18/2010
Okegawa T et al. – Hormone refractory prostate cancer patients with circulating tumor cells and/or tumor–related methylated DNA show a significantly poorer outcome than those without these blood markers.







